These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 30006684)
1. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism. Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease. Carriere CH; Kang NH; Niles LP Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722 [TBL] [Abstract][Full Text] [Related]
3. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691 [TBL] [Abstract][Full Text] [Related]
4. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta. Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183 [TBL] [Abstract][Full Text] [Related]
5. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion. Sindhu KM; Saravanan KS; Mohanakumar KP Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782 [TBL] [Abstract][Full Text] [Related]
6. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats. Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603 [TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model. Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099 [TBL] [Abstract][Full Text] [Related]
8. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease. Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761 [TBL] [Abstract][Full Text] [Related]
9. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease. Yin LH; Shen H; Diaz-Ruiz O; Bäckman CM; Bae E; Yu SJ; Wang Y BMC Neurosci; 2012 Oct; 13():120. PubMed ID: 23040108 [TBL] [Abstract][Full Text] [Related]
10. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents. Garabadu D; Agrawal N Neuromolecular Med; 2020 Jun; 22(2):314-330. PubMed ID: 31916219 [TBL] [Abstract][Full Text] [Related]
11. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions. Han B; Jin HJ; Song MY; Wang T; Zhao H Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971 [TBL] [Abstract][Full Text] [Related]
12. Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways. Jayaraj RL; Beiram R; Azimullah S; M F NM; Ojha SK; Adem A; Jalal FY Molecules; 2021 Jul; 26(15):. PubMed ID: 34361780 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats. Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688 [TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease. Falk T; Zhang S; Sherman SJ Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Park HJ; Lee PH; Ahn YW; Choi YJ; Lee G; Lee DY; Chung ES; Jin BK Eur J Neurosci; 2007 Jul; 26(1):79-89. PubMed ID: 17581257 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note. Klein A; Gidyk DC; Shriner AM; Colwell KL; Tatton NA; Tatton WG; Metz GA Behav Brain Res; 2011 Sep; 222(1):33-42. PubMed ID: 21419806 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model. Yanagida T; Takeuchi H; Kitamura Y; Takata K; Minamino H; Shibaike T; Tsushima J; Kishimoto K; Yasui H; Taniguchi T; Shimohama S Neurosci Res; 2008 Dec; 62(4):254-61. PubMed ID: 18845194 [TBL] [Abstract][Full Text] [Related]
19. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease. Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346 [TBL] [Abstract][Full Text] [Related]
20. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models. Sun H; He X; Liu C; Li L; Zhou R; Jin T; Yue S; Feng D; Gong J; Sun J; Ji J; Xiang L ACS Chem Neurosci; 2017 Jan; 8(1):155-164. PubMed ID: 27731637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]